FDA Prioritizes Shortages Post-Pandemic
US Agency On Resuming Normal Manufacturing Operations When COVID-19 Recedes
Executive Summary
Guidance from the FDA urges a focus on restarting production, easing drug shortages and completing quality assurance activities for quarantined batches when the coronavirus pandemic recedes.